Chemotherapy for Breast Cancer
- Cyclophosphamide (Cytoxan), methotrexate (Amethopterin, Mexate, Folex), and 5-fluorouracil (l, 5-FU, Adrucil)—abbreviated CMF
- Cyclophosphamide, doxorubicin (Adriamycin), and fluorouracil—abbreviated CAF
- Doxorubicin (Adriamycin) and cyclophosphamide—abbreviated AC
- Doxorubicin (Adriamycin) and cyclophosphamide followed by paclitaxel (Taxol), docetaxel concurrent with AC, or docetaxel (Taxotere)—abbreviated TAC
- Doxorubicin (Adriamycin), followed by CMF
- Docetaxel (Taxotere) and cyclophosphamide—abbreviated TC
- Cyclophosphamide, epirubicin (Ellence), and fluorouracil with or without docetaxel
- Nausea and vomiting
- Fatigue or tiredness sometimes as a result of suppression by the chemotherapeutic drugs of the blood forming cells in the bone marrow
- Hair loss
- “Fogginess” or “chemo brain,” usually mild and inconvenient, but usually not serious or permanent
- Low blood cell counts (red cells, white cells, or platelets) that can lead to infection or bleeding
- Voice change (which may be important to singers, actors, and others who use their voice in employment)
- Allergic reactions
American Lung Association website. Available at: http://www.lungusa.org . Accessed January 27, 2006.
Breast cancer. National Cancer Institute website. Available at: http://www.cancer.gov . Accessed January 27, 2006.
Detailed guide: breast cancer. American Cancer Society website. Available at: http://www.cancer.org . Accessed January 27, 2006.
- Reviewer: Mohei Abouzied, MD
- Review Date: 09/2012 -
- Update Date: 09/11/2012 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.